LINDA K. MCCOY, PHARM.D.
This content is PDF only. Please click on the PDF icon to access.
To the editor: In reviewing "Neutralizing Capacity and Cost Effectiveness of Antacids" (1), I have discovered a few errors in the listings of Table 1 for the sodium content of the antacids. Of particular importance is the listing for Delcid (Merrell-National Laboratories, Cincinnati, Ohio), which should be 15 mg/5 mL and not 1.5 mg/5 mL. Other discrepancies are probably due to the manufacturers' reformulations of the products. According to the most recent product information, the following changes have occurred: Maalox TC (W. H. Rorer, Inc., Fort Washington, Pennsylvania), 0.8 mg/5 mL; Riopan Plus (Ayerst Laboratories, New York, New York), 0.3
MCCOY LK. Correction: Antacids Tabulation. Ann Intern Med. 1981;95:394. doi: https://doi.org/10.7326/0003-4819-95-3-394_1
Download citation file:
Published: Ann Intern Med. 1981;95(3):394.
Copyright © 2020 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use